BAKER BROS ADVISORS LLC Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 25.24 | 30,000 | 757,200 | 30,000 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | P | 0.00 | 1,904,850 | 0 | 5,444,957 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | P | 0.00 | 95,150 | 0 | 489,234 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 3,540,107 | 0 | 3,540,107 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 3,540,107 | 0 | 0 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 394,084 | 0 | 394,084 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 394,084 | 0 | 0 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 920,361 | 0 | 0 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 89,878 | 0 | 0 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 2,302,669 | 0 | 0 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | C | 0.00 | 219,852 | 0 | 0 | |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Buy | C | 0.00 | 3,223,030 | 0 | 3,223,030 | 0 to 3.2 M |
| Jun 26 2019 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Buy | C | 0.00 | 309,730 | 0 | 309,730 | 0 to 309.7 K |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 52.41 | 13,166 | 690,030 | 13,166 | |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 7,641,248 | 7.6 M to 7.6 M (+0.03 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 1,216,485 | 1.2 M to 1.2 M (+0.16 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 243,801 | 241.9 K to 243.8 K (+0.79 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 159,429 | 157.5 K to 159.4 K (+1.21 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 51,803 | 49.9 K to 51.8 K (+3.83 %) |
| Jun 18 2019 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,910 | 0 | 173,001 | 171.1 K to 173 K (+1.12 %) |
| Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 220,141 | 0 | 281,190 | 61 K to 281.2 K (+360.60 %) |
| Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 220,141 | 0 | 278,773 | 58.6 K to 278.8 K (+375.46 %) |
| Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 692,706 | 0 | 0 | 692.7 K to 0 (-100.00 %) |
| Jun 07 2019 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 1,603,238 | 0 | 2,826,766 | 4.4 M to 2.8 M (-36.19 %) |
| Jun 07 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 74,229 | 0 | 181,733 | 107.5 K to 181.7 K (+69.05 %) |
| Jun 07 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 74,229 | 0 | 181,740 | 107.5 K to 181.7 K (+69.04 %) |
| Jun 07 2019 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 1,002,483 | 0 | 4,302,354 | 5.3 M to 4.3 M (-18.90 %) |
| Jun 07 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 14,840 | 0 | 14,840 | 0 to 14.8 K |
| Jun 07 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 14,840 | 0 | 14,840 | 0 to 14.8 K |
| Jun 07 2019 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 200,423 | 0 | 98,980 | 299.4 K to 99 K (-66.94 %) |
| Jun 07 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 31,229 | 0 | 102,876 | 71.6 K to 102.9 K (+43.59 %) |
| Jun 07 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 31,229 | 0 | 102,876 | 71.6 K to 102.9 K (+43.59 %) |
| Jun 07 2019 | ACAD | ACADIA PHARMACEUTI ... | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 421,756 | 0 | 3,315,146 | 3.7 M to 3.3 M (-11.29 %) |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 880 | 70 | 880 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 1,660 | 133 | 1,660 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,256 | 500 | 6,256 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 880 | 70 | 880 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 1,660 | 133 | 1,660 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,256 | 500 | 6,256 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 6,009 | 481 | 0 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 11,337 | 907 | 0 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | J | 0.08 | 42,724 | 3,418 | 0 | |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | J | 0.00 | 21,929 | 0 | 21,929 | 0 to 21.9 K |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Buy | J | 0.00 | 21,929 | 0 | 21,929 | 0 to 21.9 K |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | J | 0.00 | 59,267 | 0 | 0 | 59.3 K to 0 (-100.00 %) |
| Jun 07 2019 | IDRA | IDERA PHARMACEUTIC ... | BAKER BROS. ADVISORS LP | 10% Owner | Sell | J | 0.00 | 178,967 | 0 | 347,757 | 526.7 K to 347.8 K (-33.98 %) |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 9.23 | 129,220 | 1,192,701 | 129,220 | |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 43,109 | 0 | 43,109 | 0 to 43.1 K |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 43,109 | 0 | 43,109 | 0 to 43.1 K |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 582,200 | 0 | 18,591 | 600.8 K to 18.6 K (-96.91 %) |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 13,516 | 0 | 20,618 | 7.1 K to 20.6 K (+190.31 %) |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | J | 0.00 | 13,516 | 0 | 20,618 | 7.1 K to 20.6 K (+190.31 %) |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | J | 0.00 | 182,539 | 0 | 1,028,034 | 1.2 M to 1 M (-15.08 %) |
| Jun 05 2019 | KOD | Kodiak Sciences In ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 10.13 | 24,747 | 250,687 | 24,747 |